CareerCross uses cookies to enhance your experience on our websites. If you continue to view our sites without changing your browser settings, then it is assumed that we have your consent to collect and utilise your cookies. If you do not want to give us your consent, then please change the cookie settings on your browser. Please refer to our privacy policy for more information.
CareerCross uses cookies to enhance your experience on our websites. If you continue to view our sites without changing your browser settings, then it is assumed that we have your consent to collect and utilise your cookies. If you do not want to give us your consent, then please change the cookie settings on your browser. Please refer to our privacy policy for more information.
Typewriter TX Japan GK
Company Description
Typewriter Therapeutics is a start-up company that focuses on the commercialization of mRNA-based gene therapies using a cutting-edge platform technology that enables the targeted insertion of therapeutic genes. Founded in February 2022, the company builds on the research of Professor Emeritus Haruhiko Fujiwara of the University of Tokyo on transposons. With research facilities in Tokyo and Cambridge, USA, Typewriter is committed to bringing Japan-originated technology to the global stage. The company aims to provide innovative gene therapies to patients suffering from severe genetic disorders.
Company Details
- Head Office
- Japan
- Main Business
- 次世代ゲノム編集技術（Gene Writing）を活用した遺伝子治療薬の研究開発
- Established
- 2023年1月
- URL
- https://www.typewritertx.com/jp/
Offices
- Main Office
-
Tōkatsu Techno Plaza, Room 613
5-4-6 Kashiwa-no-Ha, Ka-shi Wa-shi
Chiba, Japan, 2770882
